R&D Systems Inc. Tocris Bioscience Boston Biochem

SR 11302

Cat. No. 2476

SR 11302 C26H32O2 [160162-42-5]

Price and Availability

For SR 11302 pricing & availability please select your country from the drop down menu:
Submit
By clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy.

Chemical Name: (E,E,Z,E)-3-Methyl-7-(4-methylpheny­l)-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-n­onatetraenoic acid

Biological Activity

Inhibitor of activator protein-1 (AP-1) transcription factor activity that displays antitumor effects in vivo. Does not activate transcription from the retinoic acid response element (RARE) and displays no activity at retinoic acid receptors (EC50 > 1 μM for RARα, RARβ, RARγ and RXRα).

Technical Data

M.Wt:
376.54
Formula:
C26H32O2
Solubility:
Soluble to 100 mM in DMSO and to 10 mM in ethanol
Purity:
>98 %
Storage:
Store at -20°C
CAS No:
160162-42-5

The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.

Certificate of Analysis / Safety Data Sheet

Certificate of Analysis: View current batch
Select another batch:
Safety Data Sheet: View Safety Data Sheet

References

Huang et al (1997) Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid. Proc.Natl.Acad.Sci.USA 94 5826.

Shiohara et al (1999) Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro. Blood 93 2057. PMID: 10068679.

Fanjul et al (2002) A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature 372 107.

If you know of a relevant citation for this product please let us know.

Keywords: SR 11302, supplier, inhibitors, AP-1, transcription, factors, antitumor, agent, SR11302

Quick Order

Find multiple products by catalog number

divider line

Cancer Research Guide

Request your free copy

Cancer Research Guide

Highlights over 350 products for cancer research. Request a copy or view PDF today.

divider line

New Product Guide

NPG

Highlights over 130 new products added in 2012. Request a copy or view PDF today.

divider line

New Products in this Area

ML 228

HIF pathway activator

TAT 14

Nrf2 pathway activator; blocks Nrf2/Keap1 interaction

KC7F2

HIF-1α inhibitor; down-regulates HIF-1α protein synthesis

Sign-up for new product e-alerts
divider line

Tocris Events

Win a Kindle

event

5th Conference on Advances in Molecular Mechanisms Underlying Neurological Disorders

June 23 - 26, 2013

Bath, UK